A randomized, prospective, comparative, multicentre trial of a single combination versus alternating combinations of antitumour drugs in advanced breast cancer
- 1 August 1987
- journal article
- research article
- Published by Elsevier in European Journal of Cancer and Clinical Oncology
- Vol. 23 (8) , 1155-1162
- https://doi.org/10.1016/0277-5379(87)90149-0
Abstract
No abstract availableThis publication has 18 references indexed in Scilit:
- Salvage therapy in advanced breast cancerEuropean Journal of Cancer and Clinical Oncology, 1985
- The eastern cooperative oncology group experience with cyclophosphamide, adriamycin, and 5-fluorouracil (CAF) in patients with metastatic breast cancerCancer, 1985
- High-dose cyclophosphamide and 5-fluorouracil versus vincristine, doxorubicin, and cyclophosphamide in advanced carcinoma of the breast: A phase III study of the piedmont oncology association (POA)Cancer, 1984
- Mitoxantrone in advanced breast cancer—a phase II study with special attention to cardiotoxicityEuropean Journal of Cancer and Clinical Oncology, 1984
- Chemotherapy of breast cancer: Current views and resultsInternational Journal of Radiation Oncology*Biology*Physics, 1983
- Adjuvant chemotherapy of breast cancerCancer, 1979
- Vindesine a review of phase-II trialsCancer Chemotherapy and Pharmacology, 1979
- SHORT-COURSE CYCLICAL CHEMOTHERAPY IN ADVANCED BREAST CANCERThe Lancet, 1977
- Assessment of response to therapy in advanced breast cancer.A project of the programme on clinical oncology of the International Union against Cancer, Geneva, SwitzerlandCancer, 1977
- COMPARISON OF 5-DAY, 1-DAY, AND 2-DAY CYCLICAL COMBINATION CHEMOTHERAPY IN ADVANCED BREAST CANCERThe Lancet, 1975